🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prevention of Acute Cholecystitis With ETGBD

RecruitingNAAges 19 Years - anyAllSeoul National University Hospital
NCT06287112 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn about Efficacy of the ETGBD parallel insertion with fully covered self-expandable metal stent for preventing acute cholecystitis in patients with low cystic duct insertion. In this study, we hypothesized that endoscopic transpapillary gallbladder drainage (ETGBD) with parallel insertion of a fully covered self-expanding metal stent(FCSEMS) through an endoscopic biliary drainage tunnel is superior in preventing complications such as cholecystitis when the gallbladder ducts confluence within the distal third of the common bile duct. And we aimed to confirm its efficacy by comparing the frequency, severity, and rate of invasive additional procedures due to cholecystitis complications to provide evidence of clinical utility.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Adults 19 years of age or older 2. Patients requiring endoscopic retrograde cholangiography and drainage for therapeutic purposes. 3. Patients with imaging (CT, Cholangiogram) confirmed confluence of the cystic duct with the distal third of the common bile duct. 4. Patients who have voluntary informed consent to participate in the study. Exclusion Criteria: * Patients who have undergone percutaneous/surgical bile duct or gallbladder drainage prior to study enrollment. * Patients with anatomic deformity of the upper gastrointestinal tract after gastric or hepatobiliary surgery * Patients with concomitant gastric/duodenal obstruction * Patients with confirmed or suspected cystic duct obstruction on imaging studies * Patients with acute cholecystitis, acute pancreatitis * Patients who underwent cholecystectomy * Patients with a life expectancy of less than 3 months * Patients who are otherwise unable to undergo endoscopic retrograde cholangiopancreatography
💊

What it tests

  • Endoscopic transpapillary gallbladder drainage (ETGBD)
📍

Where

1 site
Seoul National University Hospital
Seoul, South Korea
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy